- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
COVID-19: A catalyst to expand dermatologic care
Could the eased telehealth restrictions implemented in response to the COVID-19 pandemic allow for greater access to dermatologic care? We sat down with experts to explore how telehealth could be used to expand quality care to vulnerable and underserved populations across the United States.
In part one of our interview, Sepideh Ashrafzadeh, co-author and fourth year medical student, Harvard Medical School, Boston, discusses how the current pandemic presents a unique opportunity to expand dermatologic care to underserved and underrepresented populations.
Stay tuned: In part two of our conversation, co-author Vinod E. Nambudiri, M.D., MBA, dives into the disparities that most affect the specialty of dermatology.
Reference
Ashrafzadeh S, Nambudiri VE. The COVID-19 crisis: A unique opportunity to expand dermatology to underserved populations. J Am Acad Dermatol. 2020;83(1):e83-e84. doi:10.1016/j.jaad.2020.04.154
